Metethoheptazine - Misplaced Pages

Group of stereoisomers Pharmaceutical compound

Metethoheptazine
Clinical data


Other names	WY-535
ATC code	none
Identifiers
IUPAC name ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate
CAS Number	509-84-2
PubChem CID	176888
ChemSpider	154060
UNII	S36J5ZY2TH
CompTox Dashboard (EPA)	DTXSID30862077
Chemical and physical data
Formula	C₁₇H₂₅NO₂
Molar mass	275.392 g·mol
3D model (JSmol)	Interactive image
SMILES O=C(OCC)C2(c1ccccc1)CCCN(C)CC2C
InChI InChI=1S/C17H25NO2/c1-4-20-16(19)17(15-9-6-5-7-10-15)11-8-12-18(3)13-14(17)2/h5-7,9-10,14H,4,8,11-13H2,1-3H3 Key:BOSULDNQDJLKKL-UHFFFAOYSA-N
(what is this?) (verify)

Metethoheptazine (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.

Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States. The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.

References

GB 843924, "Substituted azacycloheptanes", assigned to American Home Products
Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH (February 1965). "Metabolism of the Non-Narcotic Analgesic, WY-5355". Biochemical Pharmacology. 14 (2): 121–8. doi:10.1016/0006-2952(65)90067-5. PMID 14332457.
"Conversion Factors for Controlled Substances". Diversion Control Division. Drug Enforcement Administration, U.S. Department of Justice. Retrieved 8 October 2018.